Enorama Pharma
2.96 SEK -0.34%Be the first to follow this company
Enorama Pharma is a pharmaceutical company. The company's operations are focused on producing and developing medical nicotine chewing gum. The products are mainly sold through retailers who sell the product under their own brand. The largest market is established in the Nordic region, but also worldwide. Enorama Pharma was founded in 2006 and the head office is located in Malmö.
Revenue
1.36M
EBIT %
-3,097.79 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
ERMA
Daily low / high price
2.96 / 3.18
SEK
Market cap
179M SEK
Turnover
40.76K SEK
Volume
14K
Financial calendar
Interim report
22.05.2024
General meeting
05.06.2024
Interim report
21.08.2024
Interim report
20.11.2024
Annual report
19.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
madHat AB | 30.0 % | 30.0 % |
Swede Unipharma AB | 20.4 % | 20.4 % |
Premium
This content is for our Premium customers only.